Rasha Aboshabana

Quantitative analysis of favipiravir and hydroxychloroquine as FDA‐approved drugs for treatment of COVID‐19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids

Mona E. El Sharkasy, Manar M. Tolba, Fathalla Belal et al. · Luminescence · 2022 · 35 citations · Full text

Biological Fluids, Pharmaceutical Science, Engineering +21

First-order derivative synchronous spectrofluorimetric determination of two antihypertensive drugs, metolazone and valsartan, in pharmaceutical and biological matrices

Abdallah M. Zeid, Rasha Aboshabana, Fawzia Ibrahim · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2021 · 24 citations

Medicinal Chemistry, Pharmaceutical Science, Derivative (Chemistry) +14

Turn-off fluorescence of S,N-doped carbon dots for determination of two nitro-containing drugs in dosage forms and human plasma

Mona E. El Sharkasy, Manar M. Tolba, Fathalla Belal et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2022 · 18 citations

Medicine, Human Plasma, Analytical Chemistry +9

Thiosemicarbazide functionalized carbon quantum dots as a fluorescent probe for the determination of some oxicams: application to dosage forms and biological fluids

Mona E. El Sharkasy, Manar M. Tolba, Fathalla Belal et al. · RSC Advances · 2022 · 14 citations · Full text

Label-free green estimation of atenolol and ivabradine hydrochloride in pharmaceutical and biological matrices by synchronous spectrofluorimetry

Rasha Aboshabana, Abdallah M. Zeid, Fawzia Ibrahim · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2023 · 13 citations

Medicinal Chemistry, Biochemistry, Gas Chromatography +14